Axogen, Inc. (AXGN) shareholders
Close on Nov 17, 2026Market cap $3.31BP/E –Yield –
Ownership
Institutional holdings as of Jun 30, 2026, from 13F filings
Shares held by institutions
Holders of more than 5%
Latest Schedule 13D (active) or 13G (passive) filed by each holder
| Holder | Shares | % of class | Filing | As of |
|---|---|---|---|---|
| First Light Asset Management, LLC Joint filing with Mathew P. Arens (10.51%) | 4,625,680 | 10.51% | 13G (passive) amendment | Dec 31, 2024 |
| Mathew P. Arens Joint filing with First Light Asset Management, LLC (6.97%) | 4,072,910 | 7.58% | 13G (passive) amendment | Jun 30, 2026 |
| Divisadero Street Capital, LLC Joint filing with Divisadero Street Capital Management, LP (6.80%), William Zolezzi (6.80%) and 2 more | 3,983,783 | 6.80% | 13G (passive) | Oct 2, 2026 |
| BlackRock, Inc. | 3,342,773 | 7.80% | 13G (passive) amendment | Dec 31, 2023 |
| Morgan Stanley | 2,330,406 | 5.30% | 13G (passive) amendment | Dec 31, 2024 |
Top institutional holders
13F holdings as of Jun 30, 2026
| Holder | Shares | % of AXGN | Value | Change | % of portfolio |
|---|---|---|---|---|---|
| BlackRock, Inc. | 4,419,208 | 7.40% | $204.12M | +548,357 | 0.00% |
| First Light Asset Management, LLC | 2,748,361 | 4.60% | $126.95M | −1,254,407 | 7.72% |
| Morgan Stanley | 2,747,924 | 4.60% | $126.93M | −375,058 | 0.01% |
| Vanguard Capital Management LLC | 2,257,948 | 3.78% | $104.29M | −33,615 | 0.00% |
| Assenagon Asset Management S.A. | 2,087,300 | 3.49% | $96.41M | +706,037 | 0.06% |
| Polar Capital Holdings Plc | 1,500,822 | 2.51% | $69.32M | – | 0.16% |
| Artemis Investment Management LLP | 1,396,792 | 2.34% | $64.52M | +1,046,904 | 0.57% |
| Wellington Management Group Llp | 1,391,654 | 2.33% | $64.28M | +427,089 | 0.01% |
| Geode Capital Management, LLC | 1,375,240 | 2.30% | $63.54M | +155,099 | 0.00% |
| Citadel Advisors LLC | 1,360,831 | 2.28% | $62.86M | +1,115,777 | 0.01% |
| Wasatch Advisors LP | 1,295,949 | 2.17% | $59.86M | −561,401 | 0.39% |
| Goldman Sachs Group Inc | 1,261,519 | 2.11% | $58.27M | +678,556 | 0.01% |
| State Street Corp | 1,246,821 | 2.09% | $57.59M | +100,318 | 0.00% |
| FMR LLC | 1,222,864 | 2.05% | $56.48M | −91,156 | 0.00% |
| Hood River Capital Management LLC | 1,067,072 | 1.79% | $49.29M | New | 0.36% |
| Price T Rowe Associates Inc /Md/ | 1,018,042 | 1.70% | $47.03M | +967,257 | 0.00% |
| Rtw Investments, LP | 1,011,576 | 1.69% | $46.72M | New | 0.40% |
| Next Century Growth Investors LLC | 872,546 | 1.46% | $40.30M | +6,583 | 2.14% |
| UBS Group AG | 836,209 | 1.40% | $38.62M | +721,989 | 0.00% |
| Armistice Capital, LLC | 775,000 | 1.30% | $35.80M | −161,000 | 0.44% |
Institutional buying and selling by quarter
Positions opened, added to, reduced and closed by 13F filers
| Quarter | Holders | Shares held | % of shares | New / added | Reduced / closed | Shares bought | Shares sold |
|---|---|---|---|---|---|---|---|
| Q2 2026 | 253 | 54M | 90.4% | 53 / 111 | 64 / 18 | 14M | 10M |
| Q1 2026 | 222 | 50M | 83.6% | 48 / 84 | 63 / 30 | 16M | 5M |
| Q4 2025 | 209 | 43M | 71.3% | 55 / 66 | 66 / 15 | 8M | 6M |
| Q3 2025 | 171 | 41M | 69.1% | 36 / 52 | 52 / 19 | 7M | 5M |
| Q2 2025 | 155 | 40M | 66.7% | 17 / 64 | 45 / 41 | 6M | 5M |
| Q1 2025 | 181 | 39M | 65.2% | 29 / 75 | 51 / 18 | 7M | 4M |
| Q4 2024 | 172 | 36M | 60.4% | 33 / 45 | 66 / 17 | 4M | 4M |
| Q3 2024 | 158 | 37M | 62.3% | 44 / 49 | 40 / 9 | 10M | 5M |
| Q2 2024 | 125 | 35M | 59.4% | 19 / 48 | 34 / 15 | 6M | 11M |
| Q1 2024 | 121 | 40M | 67.6% | 13 / 38 | 42 / 15 | 7M | 2M |
| Q4 2023 | 124 | 36M | 59.6% | 24 / 36 | 39 / 19 | 9M | 6M |
| Q3 2023 | 119 | 32M | 54.0% | 11 / 52 | 36 / 25 | 5M | 5M |
Top mutual fund and ETF holders
Latest monthly portfolio reports (Form N-PORT)
226 funds held AXGN in Q2 2026, 39% of their shares through ETFs. Each fund counts once per quarter, from its quarter-end report.
| Fund | Shares | % of AXGN | Value | % of fund | As of |
|---|---|---|---|---|---|
| Vanguard Total Stock Market Index Fund | 1,596,149 | 2.67% | $73.73M | 0.00% | Jun 30, 2026 |
| iShares Russell 2000 ETF | 1,373,784 | 2.30% | $63.46M | 0.08% | Jun 30, 2026 |
| Hood River Small-Cap Growth Fund | 687,859 | 1.15% | $31.77M | 0.48% | Jun 30, 2026 |
| Vanguard Extended Market Index Fund | 609,728 | 1.02% | $28.16M | 0.03% | Jun 30, 2026 |
| T. Rowe Price New Horizons Fund, Inc. | 588,200 | 0.98% | $27.17M | 0.18% | Jun 30, 2026 |
| Fidelity Small Cap Index Fund | 575,481 | 0.96% | $24.29M | 0.07% | Jul 31, 2026 |
| Baron Discovery Fund | 532,900 | 0.89% | $24.61M | 1.35% | Jun 30, 2026 |
| Fidelity Stock Selector Small Cap Fund | 526,000 | 0.88% | $22.20M | 0.30% | Jul 31, 2026 |
| iShares Russell 2000 Growth ETF | 485,943 | 0.81% | $22.45M | 0.15% | Jun 30, 2026 |
| Vanguard Explorer Fund | 428,087 | 0.72% | $18.07M | 0.08% | Jul 31, 2026 |
| Oberweis Micro-Cap Fund | 374,500 | 0.63% | $17.30M | 1.07% | Jun 30, 2026 |
| Wasatch Small Cap Growth Fund | 309,995 | 0.52% | $14.32M | 1.22% | Jun 30, 2026 |
| Nomura Small Cap Growth Fund | 308,159 | 0.52% | $14.23M | 1.22% | Jun 30, 2026 |
| Fidelity Series Small Cap Opportunities Fund | 302,000 | 0.51% | $12.75M | 0.27% | Jul 31, 2026 |
| First Eagle Small Cap Opportunity Fund | 299,757 | 0.50% | $12.65M | 0.44% | Jul 31, 2026 |
Officers, directors and major owners
People who filed Forms 3, 4 or 5 in the last two years
| Name | Role | Shares owned | % of shares | Latest filing |
|---|---|---|---|---|
| Marc A. Began | EVP & General Counsel | 50,135 | 0.08% | Aug 12, 2026 |
| Jens Kemp | Chief Marketing Officer | 72,451 | 0.12% | May 8, 2026 |
| Doris Quackenbush | Sales VP | 96,294 | 0.16% | May 8, 2026 |
| Lindsey Marie Hartley | CFO | 65,146 | 0.11% | May 8, 2026 |
| Erick Wayne DeVinney | Chief Innovation Officer | 262,781 | 0.44% | Mar 18, 2026 |
| Michael D. Dale | Chief Executive Officer | 63,537 | 0.11% | Feb 27, 2026 |
| Nir Naor | CFO | 260,868 | 0.44% | Jan 6, 2025 |
| Joseph A. Tyndall | Director | 10,650 | 0.02% | Sep 4, 2026 |
| Amy McBride Wendell | Director | 107,976 | 0.18% | Aug 12, 2026 |
| Kathy Johnson Weiler | Director | 0 | – | Aug 11, 2026 |
| Alan M. Levine | Director | 50,893 | 0.09% | Jun 26, 2026 |
| William P. Mr. Burke | Director | 21,850 | 0.04% | Jun 26, 2026 |
| Paul Thomas | Director | 32,395 | 0.05% | Jun 26, 2026 |
| John Johnson | Director | 14,150 | 0.02% | Jun 26, 2026 |
| Guido J. Neels | Director | 3,457,854 | 5.79% | Jun 11, 2025 |
Insider trades
Common stock transactions reported on Form 4, newest first
| Insider | Date | Transaction | Shares | Price | Value | Shares after |
|---|---|---|---|---|---|---|
| Joseph A. Tyndall Director | Sep 2, 2026 | Sale(10b5-1 plan) | −3,500 | $49.70 | $173.95K | 10,650 |
| Amy McBride Wendell Director | Aug 11, 2026 | Sale(10b5-1 plan) | −13,353 | $48.42 | $646.55K | 107,976 |
| Amy McBride Wendell Director | Aug 11, 2026 | Option exercise | +13,353 | $14.85 | $198.29K | 121,329 |
| Marc A. Began EVP & General Counsel | Aug 10, 2026 | Sale(10b5-1 plan) | −67,500 | $47.35 | $3.20M | 50,135 |
| Marc A. Began EVP & General Counsel | Aug 10, 2026 | Option exercise | +67,500 | $8.16 | $550.80K | 117,635 |
| Kathy Johnson Weiler Director | Aug 7, 2026 | Sale(10b5-1 plan) | −14,150 | $45.30 | $641.00K | 0 |
| Joseph A. Tyndall Director | Jun 19, 2026 | Option exercise | +14,150 | – | – | 14,150 |
| John Johnson Director | Jun 19, 2026 | Option exercise | +14,150 | – | – | 14,150 |
| Amy McBride Wendell Director | Jun 19, 2026 | Option exercise | +14,150 | – | – | 107,976 |
| Kathy Johnson Weiler Director | Jun 19, 2026 | Option exercise | +14,150 | – | – | 14,150 |
| Paul Thomas Director | Jun 19, 2026 | Option exercise | +18,867 | – | – | 32,395 |
| William P. Mr. Burke Director | Jun 19, 2026 | Option exercise | +14,150 | – | – | 14,250 |
| Alan M. Levine Director | Jun 19, 2026 | Option exercise | +14,150 | – | – | 50,893 |
| Amy McBride Wendell Director | May 8, 2026 | Sale | −1,647 | $42.60 | $70.16K | 93,826 |
| Amy McBride Wendell Director | May 8, 2026 | Option exercise | +1,647 | $14.85 | $24.46K | 95,473 |
| John Johnson Director | May 7, 2026 | Sale | −11,050 | $43.26 | $478.02K | 0 |
| John Johnson Director | May 7, 2026 | Option exercise | +11,050 | $7.04 | $77.79K | 11,050 |
| Doris Quackenbush Sales VP | May 7, 2026 | Sale | −3,878 | $43.51 | $168.73K | 92,416 |
| Lindsey Marie Hartley CFO | May 7, 2026 | Sale | −573 | $43.67 | $25.02K | 65,146 |
| Lindsey Marie Hartley CFO | May 7, 2026 | Option exercise | +2,500 | $8.20 | $20.50K | 63,234 |
| Lindsey Marie Hartley CFO | May 7, 2026 | Sale | −478 | $43.67 | $20.87K | 62,756 |
| Lindsey Marie Hartley CFO | May 7, 2026 | Option exercise | +2,963 | $8.27 | $24.50K | 65,719 |
| Kathy Johnson Weiler Director | May 7, 2026 | Sale | −16,344 | $44.09 | $720.61K | 0 |
| Kathy Johnson Weiler Director | May 7, 2026 | Option exercise | +16,344 | $6.95 | $113.59K | 16,344 |
| Jens Kemp Chief Marketing Officer | May 7, 2026 | Sale | −4,000 | $43.44 | $173.76K | 72,451 |
| Erick Wayne DeVinney Chief Innovation Officer | Mar 16, 2026 | Sale | −5,221 | $32.84 | $171.46K | 262,781 |
| Erick Wayne DeVinney Chief Innovation Officer | Mar 16, 2026 | Option exercise | +11,575 | – | – | 268,002 |
| Erick Wayne DeVinney Chief Innovation Officer | Mar 16, 2026 | Option exercise | +6,363 | – | – | 259,297 |
| Erick Wayne DeVinney Chief Innovation Officer | Mar 16, 2026 | Tax withholding | −2,870 | $32.84 | $94.25K | 256,427 |
| Lindsey Marie Hartley CFO | Mar 16, 2026 | Option exercise | +4,000 | – | – | 59,276 |
| Lindsey Marie Hartley CFO | Mar 16, 2026 | Option exercise | +5,000 | – | – | 62,702 |
| Lindsey Marie Hartley CFO | Mar 16, 2026 | Tax withholding | −1,968 | $32.84 | $64.63K | 60,734 |
| Lindsey Marie Hartley CFO | Mar 16, 2026 | Tax withholding | −1,574 | $32.84 | $51.69K | 57,702 |
| Jens Kemp Chief Marketing Officer | Mar 1, 2026 | Tax withholding | −2,952 | $30.65 | $90.48K | 76,451 |
| Erick Wayne DeVinney Chief Innovation Officer | Mar 1, 2026 | Tax withholding | −11,276 | $30.65 | $345.61K | 252,934 |
| Marc A. Began EVP & General Counsel | Mar 1, 2026 | Option exercise | +11,250 | – | – | 54,562 |
| Marc A. Began EVP & General Counsel | Mar 1, 2026 | Tax withholding | −4,427 | $30.65 | $135.69K | 50,135 |
| Jens Kemp Chief Marketing Officer | Feb 26, 2026 | Award | +50,670 | – | – | 94,817 |
| Jens Kemp Chief Marketing Officer | Feb 26, 2026 | Tax withholding | −15,414 | $31.90 | $491.71K | 79,403 |
| Erick Wayne DeVinney Chief Innovation Officer | Feb 26, 2026 | Award | +33,780 | – | – | 274,912 |
| Erick Wayne DeVinney Chief Innovation Officer | Feb 26, 2026 | Tax withholding | −10,702 | $31.90 | $341.39K | 264,210 |
| Marc A. Began EVP & General Counsel | Feb 26, 2026 | Award | +33,780 | – | – | 52,065 |
| Marc A. Began EVP & General Counsel | Feb 26, 2026 | Tax withholding | −8,753 | $31.90 | $279.22K | 43,312 |
| Lindsey Marie Hartley CFO | Feb 26, 2026 | Tax withholding | −6,630 | $31.90 | $211.50K | 55,276 |
| Lindsey Marie Hartley CFO | Feb 26, 2026 | Award | +17,453 | – | – | 61,906 |
| Lindsey Marie Hartley CFO | Feb 22, 2026 | Award | +17,500 | – | – | 51,157 |
| Lindsey Marie Hartley CFO | Feb 22, 2026 | Tax withholding | −6,704 | $35.38 | $237.19K | 44,453 |
| Kathy Johnson Weiler Director | Dec 16, 2025 | Sale | −21,825 | $29.55 | $644.93K | 6,580 |
| Kathy Johnson Weiler Director | Dec 16, 2025 | Sale | −18,248 | $29.55 | $539.23K | 28,405 |
| Kathy Johnson Weiler Director | Dec 16, 2025 | Sale | −6,580 | $29.55 | $194.44K | 0 |
| Kathy Johnson Weiler Director | Dec 16, 2025 | Option exercise | +21,825 | $6.95 | $151.68K | 46,653 |
| Kathy Johnson Weiler Director | Dec 16, 2025 | Option exercise | +18,248 | $7.04 | $128.47K | 24,828 |
| Amy McBride Wendell Director | Dec 16, 2025 | Option exercise | +18,248 | $7.04 | $128.47K | 137,510 |
| Amy McBride Wendell Director | Dec 16, 2025 | Sale | −20,436 | $29.31 | $598.98K | 112,074 |
| Amy McBride Wendell Director | Dec 16, 2025 | Sale | −5,000 | $29.31 | $146.55K | 132,510 |
| Amy McBride Wendell Director | Dec 16, 2025 | Sale | −18,248 | $29.31 | $534.85K | 93,826 |
| Amy McBride Wendell Director | Dec 16, 2025 | Option exercise | +5,000 | $8.95 | $44.75K | 98,826 |
| Amy McBride Wendell Director | Dec 16, 2025 | Option exercise | +20,436 | $6.30 | $128.75K | 119,262 |
| Lindsey Marie Hartley CFO | Dec 15, 2025 | Sale | −14,812 | $29.86 | $442.29K | 31,376 |
| Lindsey Marie Hartley CFO | Dec 15, 2025 | Option exercise | +14,812 | $8.27 | $122.50K | 46,188 |
Awards, option exercises, tax withholding and gifts are shown alongside open-market buys and sales. Each name links to the filing on SEC EDGAR.
Short interest
Shares sold short and not yet bought back, as of Oct 30, 2026 (FINRA, reported twice a month)
Shares sold short, last 12 months
Short sale volume counts trades marked short on any given day, including market-maker hedging, so it runs far higher than the share of Axogen's stock actually held short. Settlement fails (shares not delivered on time) peaked at 94,989 shares on Aug 27, 2026 over the last 90 days.
Planned insider sales
Notices of proposed sale filed on Form 144 before shares are sold
| Seller | Filed | Shares | Market value | Planned sale | Acquired through |
|---|---|---|---|---|---|
| Joseph A. Tyndall Director | Sep 2, 2026 | 3,500 | $174.58K | Sep 2, 2026 | Restricted Stock Units |
| Amy McBride Wendell Director | Aug 11, 2026 | 13,353 | $643.88K | Aug 11, 2026 | Exercise of Stock Options |
| Marc A. Began Officer | Aug 10, 2026 | 67,500 | $3.13M | Aug 10, 2026 | Exercise of Stock Options |
| Kathy Johnson Weiler Director | Aug 7, 2026 | 14,150 | $627.55K | Aug 7, 2026 | Restricted Stock Units |
| Amy McBride Wendell Director | May 8, 2026 | 1,647 | $70.16K | May 8, 2026 | Stock Option Exercise |
| Jens Kemp Officer | May 7, 2026 | 4,000 | $173.76K | May 7, 2026 | Restricted Stock |
| Kathy Johnson Weiler Director | May 7, 2026 | 16,344 | $720.63K | May 7, 2026 | Stock Option Exercise |
| Doris Quackenbush Vice President of Sales | May 7, 2026 | 3,878 | $168.72K | May 7, 2026 | Restricted Stock |
| John Johnson Director | May 7, 2026 | 11,050 | $477.97K | May 7, 2026 | Stock Option Exercise |
| Amy McBride Wendell Director | Dec 16, 2025 | 43,684 | $1.28M | Dec 16, 2025 | Stock Option Exercise |
| Kathy Johnson Weiler Director | Dec 16, 2025 | 46,653 | $1.38M | Dec 16, 2025 | Restricted Stock |
| Lindsey Marie Hartley Officer | Dec 15, 2025 | 14,812 | $442.29K | Dec 15, 2025 | Stock Option Exercise |
| Marc A. Began Officer | Dec 11, 2025 | 13,222 | $396.66K | Dec 11, 2025 | Performance Shares |
| Michael D. Dale Officer | Dec 10, 2025 | 25,000 | $750.00K | Dec 10, 2025 | Performance Shares |
| John Johnson Director | Dec 9, 2025 | 21,686 | $650.19K | Dec 9, 2025 | Restricted Stock |
Congress trades
2 trades in Axogen reported by 1 member of the House
| Member | Type | Traded | Amount | Filed |
|---|---|---|---|---|
| Donna Shalala FL27 | Sold | Jun 24, 2019 | $1K–15K | Apr 27, 2020 308 days late |
| Donna Shalala FL27 | Bought | Apr 16, 2019 | $1K–15K | Apr 27, 2020 377 days late |
See a number that looks wrong?